Harve Wilson

Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-spiro[cycloalkane-1,3'-[3H]indol]-2'(1'H)-ones

David W. Robertson, Joseph H. Krushinski, G. Don Pollock et al. · Journal of Medicinal Chemistry · 1987 · 80 citations

Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine

David W. Robertson, E. E. Beedle, Joseph H. Krushinski et al. · Journal of Medicinal Chemistry · 1985 · 73 citations

Combinatorial Chemistry, Heterocyclic, Biochemistry +14

Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinone

David W. Robertson, E. E. Beedle, J. K. SWARTZENDRUBER et al. · Journal of Medicinal Chemistry · 1986 · 66 citations · Full text

Bipyridine Cardiotonics, Cardiac Muscle, Heart Rate +14

Dihydropyridazinone cardiotonics. The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one

David W. Robertson, Joseph H. Krushinski, E. E. Beedle et al. · Journal of Medicinal Chemistry · 1986 · 56 citations

Medicinal Chemistry, Bioorganic Chemistry, Pharmacological Study +15

Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.

Charles V. Jackson, V G Crowe, Judit Frank et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 28 citations